Owing to the potentials of the TIL subset density to predict prognosis of GIST, we wondered whether combining two or three of the independent prognostic immune parameters (TIM-3, CD8, and CD56) would improve the prediction efficiency. This evidence concerns the gene HAVCR2 and gastrointestinal stromal tumor.